A genetic variant carried by 25% of the population may be silently rewiring brain circuits decades before any memory problems emerge, fundamentally changing our understanding of Alzheimer's prevention windows. The discovery reveals that APOE4—the strongest genetic risk factor for late-onset Alzheimer's—doesn't just increase amyloid accumulation as long believed, but actively disrupts normal brain electrical activity from an early age. Using advanced brain imaging in young mice with normal cognitive function, researchers detected abnormal hyperactivity in hippocampal memory circuits among APOE4 carriers. This electrical storm preceded any detectable memory decline, suggesting the brain's information processing becomes compromised long before traditional symptoms appear. The hyperexcitability stems directly from neuronal APOE4 protein expression, not secondary effects from brain inflammation or protein deposits. Most significantly, the team identified Nell2 as a molecular target that can reverse this hyperactivity when modulated. This finding represents a paradigm shift from viewing APOE4 as merely increasing disease susceptibility to recognizing it as actively driving pathological brain states from youth onward. The implications extend far beyond Alzheimer's research, as hippocampal hyperexcitability appears in multiple neurodegenerative conditions and may represent a common early pathway to cognitive decline. For the estimated 75 million Americans carrying APOE4, this research suggests intervention windows may open decades earlier than previously thought, potentially before any subjective cognitive changes occur. However, translating mouse findings to human prevention strategies requires extensive validation, and the complexity of targeting brain electrical activity presents significant therapeutic challenges.